Pernix Therapeutics (PTX) – Major News
-
Pernix Therapeutics (PTX) Enters into Asset Purchase Agreement with Certain Funds Managed by Highbridge Capital Management, Files for Chapter 11 Protection
-
Pernix Therapeutics (PTX) Reports Prelim. Q2 Revenue of $33M-$35M
-
Pernix Therapeutics (PTX) Reports Q4 Net Loss of $81.7M
-
Pernix Therapeutics (PTX) Reports Q3 Loss of $2.99/Share
-
Pernix Therapeutics (PTX) Reports Q2 Loss of $0.47/Share
-
Pernix Therapeutics (PTX) to Cut 23% of Workforce in Restructuring
-
Pernix Therapeutics (PTX) Announces Significant Data from Silenor Phase IV vs. Zolpidem
-
Pernix Therapeutics (PTX) CEO Doug Drysdale to Step Down
-
Pernix Therapeutics (PTX) Misses Q1 EPS by 36c, Withdraws Guidance
-
Pernix Therapeutics (PTX) Misses Q3 EPS by 19c
-
Pernix Therapeutics (PTX) Misses Q2 EPS by 15c
-
Pernix Therapeutics (PTX) Posts Q1 Loss of 62c/Share
-
Pernix Therapeutics (PTX) Guides Q1 Revenue Below Expectations; Updates on FY15 Outlook
-
Pernix Therapeutics (PTX) to Acquire Zogenix's (ZGNX) Zohydro ER Business
-
Pernix Therapeutics (PTX) Tops Q4 EPS by 7c
-
Pernix Therapeutics (PTX) Posts Q3 Loss of 2c/Share
-
Pernix Therapeutics Holdings (PTX) Posts Q2 GAAP Loss of 16c/Share
-
Pernix Therapeutics Holdings (PTX) Posts Q1 Loss of 26c/Share
-
Pernix Therapeutics Holdings (PTX) Posts Q4 Loss of 15c/Share
-
Pernix Therapeutics Holdings (PTX) Posts Q3 Loss of 16c/Share
-
Pernix Therapeutics Holdings (PTX) Posts Q2 Loss of 16c/Share
-
Pernix Therapeutics Holdings (PTX) Posts Surprise Q4 Loss of 5c/Share
-
Pernix (PTX) to Acquire Somaxon (SOMX) in $25M All-Stock Deal
-
Pernix Therapeutics Holdings (PTX) Posts Q3 Loss of 1c/Share
-
Pernix Therapeutics (PTX) Guides Q4, FY11 EPS, Sales
-
Pernix Therapeutics Holdings (PTX) Tops Q3 EPS by 3c
-
Pernix Therapeutics Holdings (PTX) Tops Q2 EPS by 4c
-
Pernix Therapeutics Holdings (PTX) Reports Q1 EPS of $0.04, Revenue Increased 14% Y/Y
-
Pernix Therapeutics (PTX) Reports Q4 GAAP EPS of 7c
-
Pernix Therapeutics (PTX) Posts Q3 EPS of $0.10, Stronger Y/Y
-
Pernix Therapeutics (PTX) Posts Weaker Q2 Results
Back to PTX Stock Lookup